Cite
APA Citation
Sandhu, S., Atkinson, V., Cao, M. G., Medina, T., Rivas, A. S., Menzies, A. M., Caro, I., Roberts, L., Song, Y., Yan, Y., Guo, Y., Xue, C., & Long, G. V. (2023). phase 1b study of cobimetinib plus atezolizumab in patients with advanced BRAFV600 wild-type melanoma progressing on prior anti–programmed death-1 therapy. European journal of cancer, 178, 180–190. http://access.bl.uk/ark:/81055/vdc_100172522370.0x000038